Source: Annual Congress 2003 - Pharmacological treatment strategies in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. G. Löfdahl, E. Andreasson, K. Svensson, A. Ericsson (Lund, Sweden). Budesonide/formoterol in a single inhaler improves health status in patients with COPD without increasing healthcare costs. Eur Respir J 2003; 22: Suppl. 45, 433

Member's Comments

No comment yet.

Related content which might interest you: Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Improvement in health status in patients with moderate to severe COPD after treatment with budesonide/formoterol in a single inhaler Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002 Budesonide/formoterol for the treatment of COPD exacerbations in the primary healthcare setting Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Tiotropium reduces health resource utilization associated with COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 513s Year: 2004 Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Budesonide/formoterol improves the wellbeing of patients with COPD: results from a real-life setting Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005 Nurse-assisted medical management of COPD patients at home is cost effective and improves patients‘ satisfaction considerably Source: Eur Respir J 2007; 30: Suppl. 51, 191s Year: 2007 How can we improve patient use of inhaler devices in COPD? Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Salmeterol 50mcg bid significantly improves health status in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 50s Year: 2003 QVA149 once-daily is safe and well tolerated and improves lung function and health status in Japanese patients with COPD: The ARISE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 The economic impact recurrent inhaler versus single instructions in asthma and COPD patients Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence Year: 2021 Comparison of total cost of health services among asthmatic and COPD patients in uni-speciality hospital with general hospital Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment Year: 2008 Budesonide/formoterol in a single inhaler sustains lung-function improvements in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 50s Year: 2003 Suboptimal asthma control in patients receiving long-term maintenance therapy Source: Annual Congress 2006 - The challenges of managing asthma in primary care Year: 2006 Budesonide/formoterol added to tiotropium improves exacerbations and exacerbation-related antibiotic use in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Improving asthma care with use of asthma action plan and inhaler technique check in a children‘s hospital Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 Reduced cost of unscheduled healthcare resource use in patients with well controlled asthma Source: Eur Respir J 2005; 26: Suppl. 49, 44s Year: 2005 The importance of inhaler technique education in asthma and COPD: a long-term follow-up Source: International Congress 2019 – Medical education Year: 2019